Thursday, April 16, 2026
Today's Print

Tag: Ridgeback

MSD, Ridgeback start pivotal Phase 3 MOVe-AHEAD study evaluating molnupiravir

Study now enrolling participants in the Philippines who live in the same household as someone with symptomatic, laboratory-confirmed COVID-19 MSD, known as Merck & Co.,...

MSD, Ridgeback start Pivotal Phase 3 MOVe-AHEAD Study on Molnupiravir

Study now enrolling participants in the Philippines who live in the same household as someone with symptomatic, laboratory-confirmed COVID-19 MSD, known as Merck & Co.,...
- Advertisement -spot_img
- Advertisement -spot_img